Mechanism of YC-1-induced activation of soluble guanylyl cyclase

Molecular Pharmacology

Volumn 53, Issue 1, 1998, Pages 123-127

  Friebe, Andreas ^a   Koesling, Doris ^a,b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b Institut fur Pharmakologie   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; CARBON MONOXIDE; CYCLIC GMP; GUANYLATE CYCLASE; INDAZOLE DERIVATIVE; NITRIC OXIDE; OXYHEMOGLOBIN; PROTOPORPHYRIN; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; DISSOCIATION CONSTANT; DRUG BINDING SITE; DRUG POTENTIATION; ENZYME ACTIVATION; PRIORITY JOURNAL;

EID: 0031890057     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.1.123     Document Type: Article

References (27)

1. Brüne B and Ullrich V (1987) Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 32:497-504.
2. 1 subunits. Eur J Biochem 240:380-386.
3. Friebe A, Schultz G, and Koesling D (1996) Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J 15:6863-6868.
4. Friebe A, Wedel B, Foerster J, Harteneck C, Malkewitz J, Schultz G, and Koesling D (1997) Function of conserved cysteine residues on soluble guanylyl cyclase. Biochemistry 36:1194-1198.
5. Garbers DL and Lowe DG (1994) Guanylyl cyclase receptors. J Biol Chem 269: 30741-30744.
6. Garthwaite J, Charles SL, and Chess-Williams R (1988) Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature (Lond). 336:385-388.
7. Humbert P, Niroomand F, Fischer G, Mayer B, Koesling D, Hinsch KH, Gausepohl H, Frank R, Schultz G, and Böhme E (1990) Purification of soluble guanylate cyclase from bovine lung by a new immunoaffinity chromatographic method. Eur J Biochem 190:273-278.
8. Ignarro LJ, Buga GM, Wood KS, Byrns RE, and Chandhuri G (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265-9269.
9. Ignarro LJ, Wood KS, and Wolin MS (1982) Activation of purified soluble guanylate cyclase by protoporphyrin LX. Proc Natl Acad Sci USA 79:2870-2873.
10. Ignarro LJ, Wood KS, and Wolin MS (1984) Regulation of purified soluble guanylate cyclase by porphyrins and metalloporphyrins: a unifying concept. Adv Cyclic Nucleotide Protein Phosphorylation Res 17:267-274.
11. Ingi T and Ronnett GV (1995) Direct demonstration of a physiological role for carbon monoxide in olfactory receptor neurons. J Neurosci 15:85214-82222.
12. Kharitonov VG, Sharma VS, Pilz RB, Magde D, and Koesling D (1995) Basis of guanylate cyclase activation by carbon monoxide. Proc Natl Acad Sci USA 92: 2568-2571.
13. Ko FN, Wu CC, Kuo SC, Lee FY, and Teng CM (1994) YC-1, a novel activator of platelet guanylate cyclase. Blood 84:4226-4233.
14. Leinders-Zufall T, Shepherd GM, and Zufall F (1995) Regulation of cyclic nucleotide-gated channels and membrane excitability in olfactory receptor cells by carbon monoxide. J Neurophysiol 74:1498-1508.
15. Moncada S and Higgs EA (1995) Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 9:1319-1330.
16. Morita T, Perrella MA, Lee ME, and Kourembanas S (1995) Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci USA 92:1475-1479.
17. Mülsch A, Bauersachs J, Schäfer A, Stasch JP, Kast R, and Busse R (1997) Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators. Br J Pharmacol 120:681-689.
18. Schultz G and Böhme E (1984) Guanylate cyclase. GTP pyrophosphate-lyase (cyclízing), E. C. 4.6.1.2., in Methods of Enzymatic Analysis (Bergmeyer HU, Bergmeyer J, and Graßl M, eds) Verlag Chemie, Weinheim, Germany, pp 379-389.
19. Stevens CF and Wang Y (1993) Reversal of long-term potentiation by inhibitors of heme oxygenase. Nature (Lond) 364:147-149.
20. Stone JR and Marietta MA (1994) Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry 33:5636-5640.
21. Stone JR and Marletta MA (1996) Spectral and kinetic studies on the activation of soluble guanylyl cyclase by nitric oxide. Biochemistry 35:1093-1099.
22. Utz J and Ullrich V (1991) Carbon monoxide relaxes ileum smooth muscle through activation of guanylate cyclase. Biochem Pharmacol 41:1195-1201.
23. Verma AD, Hirsch J, Glatt CE, Ronnett GV, and Snyder SH (1993) Carbon monoxide: a putative neuronal messenger. Science (Washington DC) 259:281-284.
24. Waldman SA and Murad F (1987) Cyclic GMP synthesis and function. Pharmacol Rev 39:163-196.
25. Wu CC, Ko FN, Kuo SC, Lee FY, and Teng CM (1995) YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Br J Pharmacol 116:1973-1978.
26. Zakhary R, Gaine SP, Dinerman JL, Ruat M, Flavahan NA, and Snyder SH (1996) Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc Natl Acad Sci USA 93:795-798.
27. Zhuo M, Small SA, Kandel ER, and Hawkins RD (1993) Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus. Science (Washington DC) 260:1946-1950.